Experience
Innovacell AG
University of Pittsburgh
Represented Innovacell in opposition related to muscle derived cells.
Innovacell AG v. University of Pittsburgh, T 0527/17, EPO
*Matter handled prior to joining Finnegan
Innovacell Biotechnologie AG v. University of Pittsburgh*
Innovacell Biotechnologie AG
Innovacell Biotechnologie AG v. University of Pittsburgh*
Innovacell Biotechnologie AG
Academisch Ziekenhuis Leiden v. University of Western Australia
University of Western Australia
Abbott
GlaxoSmithKline
Hyundai Electronics v. Siemens AG
Hyundai Electronics
Finnegan client BTG prevails in EPO opposition proceedings in the field of vein sclerotherapy
BTG International, Ltd.
University of Western Australia v. Academisch Ziekenhuis Leiden
Sarepta Therapeutics
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.